elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30379200-530AE235-1490-4F15-AB66-30ED1FC9BE61
Q30379200-530AE235-1490-4F15-AB66-30ED1FC9BE61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30379200-530AE235-1490-4F15-AB66-30ED1FC9BE61
Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).
P2860
Q30379200-530AE235-1490-4F15-AB66-30ED1FC9BE61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30379200-530AE235-1490-4F15-AB66-30ED1FC9BE61
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5d17fb44ffb238466f32f1dfeeffe4ba5eaf6a28
P2860
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.